212 Founders

212 Founders is the startup program of CDG Invest, the venture arm of Caisse de Depot et de Gestion, Morocco’s sovereign-aligned long-term investor. The program blends acceleration and venture capital, operating across pre-seed, seed, and Series A with checks in the $250k to $1M range, and is the most institutionalized early-stage capital provider in Morocco. AI is not a stated primary focus, but technology-enabled businesses including digital health are within the mandate. The right founder is a Moroccan or Maghreb-based operator, often a returnee from European or US technology careers, building a digital health, healthcare software, or tech-enabled care business with credible Moroccan and regional francophone Africa expansion logic. The wrong founder is a deep medtech or therapeutics team, a Series A-plus company looking for institutional growth capital, or a non-Maghreb founder using Morocco as a satellite. Intro paths run through Casablanca’s tight venture and family-business community, CDG Invest itself, the StartupBootcamp and Endeavor Morocco networks, and through frequent co-investors including UM6P Ventures, Outlierz Ventures, and the Africinvest small-cap activity. Direct application through 212 Founders’ open program cycles is the standard entry, and warm intros from cohort alumni or CDG-affiliated executives materially help. In the pitch, lead with the founding team’s depth in the Moroccan health system and the dual-language Arabic-French consumer reality, and show a credible plan to expand into francophone West Africa where Morocco has natural commercial corridors. Be specific about Ministry of Health and Agence Nationale de l’Assurance Maladie posture, the role of CNSS and CNOPS in payer dynamics, and Law 09-08 data protection compliance. Show realistic unit economics in MAD with a clear-eyed view of the dirham’s relative stability but limited consumer purchasing power. Caveats include the typical accelerator-CVC hybrid dynamics: the program takes equity, follow-on commitment varies by vintage, and the downstream syndicate of Series A investors active in Morocco is thinner than in many comparable markets. For Moroccan healthcare founders, 212 Founders is the most credible early partner; for the wrong profile, it is a forced fit.